tunicamycin (MedChemExpress)
MedChemExpress is a verified supplier 
MedChemExpress manufactures this product 
89
Structured Review
MedChemExpress
tunicamycin
Tunicamycin, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 89/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hy-n8395/Tunicamycin+V/pm38522775-96-27-38
Average 89 stars, based on 1 article reviews
Tunicamycin, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 89/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hy-n8395/Tunicamycin+V/pm38522775-96-27-38
Average 89 stars, based on 1 article reviews
tunicamycin - by Bioz Stars,
2026-10
89/100 stars
Images
Related Articles
Protein Extraction:Article Title: Pharmacological suppression of HHLA2 glycosylation restores anti-tumor immunity in colorectal cancer. Article Snippet: Immunotherapy aimed at inhibiting the negative co-stimulatory molecule programmed cell death-ligand 1 (PDL1) has limited effectiveness, with clinical response rates remaining below 10%–15%.. Therefore, new immune checkpoints need to be explored.. Our study focused on human endogenous retrovirus H long terminal repeat–associating protein 2 (HHLA2), a highly glycosylated member of the B7 family that is widely expressed in colorectal cancer. Article Title: TGFβ attenuates cartilage extracellular matrix degradation via enhancing FBXO6-mediated MMP14 ubiquitination Article Snippet: For examination of protein ubiquitination, transduced ATDC5 cells were treated without or with proteasome inhibitor, MG-132 (10μg/ml, Cell Signaling Technology) for 12hrs prior to protein extraction for immunoprecipitation and immunoblotting analyses. Western Blot:Article Title: Pharmacological suppression of HHLA2 glycosylation restores anti-tumor immunity in colorectal cancer. Article Snippet: Immunotherapy aimed at inhibiting the negative co-stimulatory molecule programmed cell death-ligand 1 (PDL1) has limited effectiveness, with clinical response rates remaining below 10%–15%.. Therefore, new immune checkpoints need to be explored.. Our study focused on human endogenous retrovirus H long terminal repeat–associating protein 2 (HHLA2), a highly glycosylated member of the B7 family that is widely expressed in colorectal cancer. Article Title: TGFβ attenuates cartilage extracellular matrix degradation via enhancing FBXO6-mediated MMP14 ubiquitination Article Snippet: For examination of protein ubiquitination, transduced ATDC5 cells were treated without or with proteasome inhibitor, MG-132 (10μg/ml, Cell Signaling Technology) for 12hrs prior to protein extraction for immunoprecipitation and immunoblotting analyses. |